Articles |
Presented in part at the 10th International Symposium on Atherosclerosis, Montreal, Canada, October 11, 1994.
From the Department of Internal Medicine (K.T., M.T.), Hiroshima Railway Hospital, Hiroshima; the Departments of Internal Medicine and Pathology (K.S., H.B., S.J., R.L., K.A.), Fukuoka University School of Medicine, Fukuoka; the Department of Pediatrics (T.O.), Kumamoto University School of Medicine, Kumamoto; the Department of Cardiology (H.S.), Hiroshima City Hospital, Hiroshima; and the Department of Internal Medicine (G.K.), Hiroshima University School of Medicine, Hiroshima, Japan. The first two authors contributed equally to this work.
Correspondence to Keijiro Saku, MD, Department of Internal Medicine, Fukuoka University School of Medicine, 45-1-7 Nanakuma Jonanku, Fukuoka 814-01, Japan.
Abstract We report a 39-year-old Japanese man with HDL
and apoA-I deficiency as well as data from members of his family.
Corneal opacity and a stomatocyte were found but not tonsillar
hypertrophy, xanthomas, or splenomegaly. His serum HDL
cholesterol, apoA-I, apoA-II, and LDL
cholesterol levels were 6 mg/dL, <3 mg/dL, 6 mg/dL, and
175 mg/dL, respectively. Plasma triglyceride, phospholipid,
apoB, apoC-III, and apoE levels were all within normal limits.
Lecithin:cholesterol acyltransferase activity was half of
normal, while lipoprotein lipase and hepatic triglyceride
lipase activities were within normal limits. ApoA-I deficiency was
confirmed by combined isoelectric focusing and sodium dodecyl
sulfatepolyacrylamide gel electrophoresis and by an
immunoblotting method. We surveyed the apoA-I gene of the patient and
five of his family members by direct sequencing after amplification by
polymerase chain reaction and found a codon 8 nonsense mutation
(TGG
TAG, Trp
stop) in exon 3 of the apoA-I gene. The results of a
pedigree analysis by DNA sequencing and restricted fragment
length polymorphism (Sty I) were consistent with
an autosomal codominant trait. Coronary angiography was
performed to evaluate coronary atherosclerosis,
but no significant luminal narrowing was detected. An
intracoronary ultrasound study showed mild intimal
hyperplasia in segment 6. In summary, this is a case of apoA-I
deficiency without evidence of coronary heart disease.
Key Words: atherosclerosis coronary heart disease gene HDL-deficient syndrome intravascular ultrasound imaging
This article has been cited by other articles:
![]() |
R. D. Santos, E. J. Schaefer, B. F. Asztalos, E. Polisecki, J. Wang, R. A. Hegele, L. R. C. Martinez, M. H. Miname, C. E. Rochitte, P. L. Da Luz, et al. Characterization of high density lipoprotein particles in familial apolipoprotein A-I deficiency J. Lipid Res., February 1, 2008; 49(2): 349 - 357. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Y. Alenezi, M. Marcil, D. Blank, M. Sherman, and J. Genest Jr. Is the Decreased High-Density Lipoprotein Cholesterol in the Metabolic Syndrome Due to Cellular Lipid Efflux Defect? J. Clin. Endocrinol. Metab., February 1, 2004; 89(2): 761 - 764. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. E. Moore, M.-a. Kawashiri, K. Kitajima, A. Secreto, J. S. Millar, D. Pratico, and D. J. Rader Apolipoprotein A-I Deficiency Results in Markedly Increased Atherosclerosis in Mice Lacking the LDL Receptor Arterioscler Thromb Vasc Biol, October 1, 2003; 23(10): 1914 - 1920. [Abstract] [Full Text] [PDF] |
||||
![]() |
References Circulation, December 17, 2002; 106(25): 3373 - 3421. [Full Text] |
||||
![]() |
W. A. Pitman, R. Korstanje, G. A. Churchill, E. Nicodeme, J. J. Albers, M. C. Cheung, M. A. Staton, S. S. Sampson, S. Harris, and B. Paigen Quantitative trait locus mapping of genes that regulate HDL cholesterol in SM/J and NZB/B1NJ inbred mice Physiol Genomics, May 10, 2002; 9(2): 93 - 102. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-L. Liao, K. Saku, J. Ou, S. Jimi, B. Zhang, K. Shirai, and K. Arakawa A Missense Mutation of the Nitric Oxide Synthase (eNOS) Gene (Glu298Asp) in Five Patients with Coronary Artery Disease: Case Reports Angiology, August 1, 1999; 50(8): 671 - 676. [Abstract] [PDF] |
||||
![]() |
A. Matsunaga, J. Sasaki, H. Han, W. Huang, M. Kugi, T. Koga, S. Ichiki, T. Shinkawa, and K. Arakawa Compound Heterozygosity for an Apolipoprotein A1 Gene Promoter Mutation and a Structural Nonsense Mutation With Apolipoprotein A1 Deficiency Arterioscler Thromb Vasc Biol, February 1, 1999; 19(2): 348 - 355. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Marcil, L. Yu, L. Krimbou, B. Boucher, J. F. Oram, J. S. Cohn, and J. Genest Jr Cellular Cholesterol Transport and Efflux in Fibroblasts Are Abnormal in Subjects With Familial HDL Deficiency Arterioscler Thromb Vasc Biol, January 1, 1999; 19(1): 159 - 169. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Mamontova, S. Seguret-Mace, B. Esposito, C. Chaniale, M. Bouly, N. Delhaye-Bouchaud, G. Luc, B. Staels, N. Duverger, J. Mariani, et al. Severe Atherosclerosis and Hypoalphalipoproteinemia in the Staggerer Mouse, a Mutant of the Nuclear Receptor ROR{alpha} Circulation, December 15, 1998; 98(24): 2738 - 2743. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Miller, D. Aiello, H. Pritchard, G. Friel, and K. Zeller Apolipoprotein A-IZavalla (Leu159->Pro) : HDL Cholesterol Deficiency in a Kindred Associated With Premature Coronary Artery Disease Arterioscler Thromb Vasc Biol, August 1, 1998; 18(8): 1242 - 1247. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Huang, J. Sasaki, A. Matsunaga, H. Nanimatsu, K. Moriyama, H. Han, M. Kugi, T. Koga, K. Yamaguchi, and K. Arakawa A Novel Homozygous Missense Mutation in the Apo A-I Gene With Apo A-I Deficiency Arterioscler Thromb Vasc Biol, March 1, 1998; 18(3): 389 - 396. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. E. Miettinen, M. Jauhiainen, H. Gylling, S. Ehnholm, A. Palomaki, T. A. Miettinen, and K. Kontula Apolipoprotein A-IFIN (Leu159->Arg) Mutation Affects Lecithin : Cholesterol Acyltransferase Activation and Subclass Distribution of HDL but Not Cholesterol Efflux From Fibroblasts Arterioscler Thromb Vasc Biol, November 1, 1997; 17(11): 3021 - 3032. [Abstract] [Full Text] |
||||
![]() |
R. Miccoli, A. Bertolotto, R. Navalesi, L. Odoguardi, A. Boni, J. Wessling, H. Funke, H. Wiebusch, A. von Eckardstein, and G. Assmann Compound Heterozygosity for a Structural Apolipoprotein A-I Variant, Apo A-I(L141R)Pisa, and an Apolipoprotein A-I Null Allele in Patients With Absence of HDL Cholesterol, Corneal Opacifications, and Coronary Heart Disease Circulation, October 1, 1996; 94(7): 1622 - 1628. [Abstract] [Full Text] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1995 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |